Cargando…

Discovery of Novel HIV Protease Inhibitors Using Modern Computational Techniques

The human immunodeficiency virus type 1 (HIV-1) has continued to be a global concern. With the new HIV incidence, the emergence of multi-drug resistance and the untoward side effects of currently used anti-HIV drugs, there is an urgent need to discover more efficient anti-HIV drugs. Modern computati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Okafor, Sunday N., Angsantikul, Pavimol, Ahmed, Hashim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9603388/ https://www.ncbi.nlm.nih.gov/pubmed/36293006 http://dx.doi.org/10.3390/ijms232012149

Ejemplares similares

Drug Reprofiling to Identify Potential HIV-1 Protease Inhibitors
por: Okafor, Sunday N., et al.
Publicado: (2023)

Cell Membrane-Coated Nanoparticles As an Emerging Antibacterial Vaccine Platform
por: Angsantikul, Pavimol, et al.
Publicado: (2015)

Freeze-drying for the preservation of immunoengineering products
por: Kommineni, Nagavendra, et al.
Publicado: (2022)

Current and Novel Inhibitors of HIV Protease
por: Pokorná, Jana, et al.
Publicado: (2009)

Deep Eutectic Solvents for Subcutaneous Delivery of Protein Therapeutics
por: Curreri, Alexander M., et al.
Publicado: (2023)

Discovery of human coronaviruses pan-papain-like protease inhibitors using computational approaches
por: Alamri, Mubarak A., et al.
Publicado: (2020)

Neutralization of cholera toxin with nanoparticle decoys for treatment of cholera
por: Das, Soumita, et al.
Publicado: (2018)

Biomimetic Targeted Theranostic Nanoparticles for Breast Cancer Treatment
por: Marshall, Suphalak Khamruang, et al.
Publicado: (2022)

Discovery of novel papain-like protease inhibitors for potential treatment of COVID-19
por: Hersi, Fatema, et al.
Publicado: (2023)

Rapid Discovery of Aspartyl Protease Inhibitors Using an Anchoring Approach
por: Konstantinidou, Markella, et al.
Publicado: (2020)

Discovery and Rational Design of a Novel Bowman-Birk Related Protease Inhibitor
por: Miao, Yuxi, et al.
Publicado: (2019)

Antiviral Drug Discovery: Norovirus Proteases and Development of Inhibitors
por: Chang, Kyeong-Ok, et al.
Publicado: (2019)

Recent progress in the discovery of inhibitors targeting coronavirus proteases
por: Wang, Haofeng, et al.
Publicado: (2016)

Computing Clinically Relevant Binding Free Energies of HIV-1 Protease Inhibitors
por: Wright, David W., et al.
Publicado: (2014)

Protease-Mediated Maturation of HIV: Inhibitors of Protease and the Maturation Process
por: Adamson, Catherine S.
Publicado: (2012)

The pharmacokinetic properties of HIV-1 protease inhibitors: A computational perspective on herbal phytochemicals
por: Kehinde, Idowu, et al.
Publicado: (2019)

A Computer-Aided Approach for the Discovery of D-Peptides as Inhibitors of SARS-CoV-2 Main Protease
por: Hernández González, Jorge E., et al.
Publicado: (2022)

Drug repurposing and computational modeling for discovery of inhibitors of the main protease (M(pro)) of SARS-CoV-2
por: Silva, José Rogério A., et al.
Publicado: (2021)

Development of Mucoadhesive Electrospun Scaffolds for Intravaginal Delivery of Lactobacilli spp., a Tenside, and Metronidazole for the Management of Bacterial Vaginosis
por: Ilomuanya, Margaret O., et al.
Publicado: (2023)

Ligand-based discovery of coronavirus main protease inhibitors using MACAW molecular embeddings
por: Dong, Jie, et al.
Publicado: (2022)

Identification of Novel Potential VEGFR-2 Inhibitors Using a Combination of Computational Methods for Drug Discovery
por: Al-Sanea, Mohammad M., et al.
Publicado: (2021)

An Assay to Monitor HIV-1 Protease Activity for the Identification of Novel Inhibitors in T-Cells
por: Hilton, Brett J., et al.
Publicado: (2010)

Cobicistat: a Novel Pharmacoenhancer for Co-Formulation with HIV Protease and Integrase Inhibitors
por: Nathan, Bavithra, et al.
Publicado: (2013)

Modern Computational Techniques for the HMMER Sequence Analysis
por: Meng, Xiandong, et al.
Publicado: (2013)

Role of Gag in HIV Resistance to Protease Inhibitors
por: Clavel, François, et al.
Publicado: (2010)

Interdependence of Inhibitor Recognition in HIV-1 Protease
por: Paulsen, Janet L., et al.
Publicado: (2017)

Discovery of M Protease Inhibitors Encoded by SARS-CoV-2
por: Hung, Hui-Chen, et al.
Publicado: (2020)

Discovery and Mechanism of SARS-CoV-2 Main Protease Inhibitors
por: Huff, Sarah, et al.
Publicado: (2021)

Alteration of HIV epitope processing and presentation by HIV protease inhibitors
por: Kourjian, G, et al.
Publicado: (2012)

Computational Simulation of HIV Protease Inhibitors to the Main Protease (Mpro) of SARS-CoV-2: Implications for COVID-19 Drugs Design
por: Yu, Wei, et al.
Publicado: (2021)

Discovery of novel SARS-CoV-2 3CL protease covalent inhibitors using deep learning-based screen
por: Wang, Liying, et al.
Publicado: (2022)

The Discovery of Modern Anæsthesia
Publicado: (1894)

Modern drug discovery for inflammatory bowel disease: The role of computational methods
por: Johnson, Titilayo Omolara, et al.
Publicado: (2023)

Modern industrial microbiology and biotechnology /
por: Okafor, Nduka
Publicado: (2007)

Accurate Prediction of Inhibitor Binding to HIV-1 Protease Using CANDOCK
por: Falls, Zackary, et al.
Publicado: (2022)

In silico screening-based discovery of novel covalent inhibitors of the SARS-CoV-2 3CL protease
por: Xiong, Muya, et al.
Publicado: (2022)

A Novel Substrate-Based HIV-1 Protease Inhibitor Drug Resistance Mechanism
por: Nijhuis, Monique, et al.
Publicado: (2007)

Evaluation of novel protease inhibitors against darunavir‐resistant variants of HIV type 1
por: Inoue, Mari, et al.
Publicado: (2016)

In Vivo Emergence of a Novel Protease Inhibitor Resistance Signature in HIV-1 Matrix
por: Datir, Rawlings, et al.
Publicado: (2020)

Discovery and Computational Analyses of Novel Small Molecule Zika Virus Inhibitors
por: Zhu, Siyu, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_3cq53019u70shvualqcscoohie